SMARCA4 mutated tumors had a significantly higher infiltration of CD163+ myeloid cells and CD163+CD68+ macrophages in the tumor compartment, and APC mutated tumors had a significantly higher infiltration of NKp46+ and CD56+NKp46+ NKT cells in the tumor and stromal compartments, and of CD68+ macrophages in the stromal compartment. This evidence concerns the gene SMARCA4 and neoplasm.